Literature DB >> 31363887

Immediate Postpartum Long-Acting Reversible Contraception Programs in Texas Hospitals Following Changes to Medicaid Reimbursement Policy.

Ashley V Hill1,2, Eileen Nehme3, Nagla Elerian3, Ella D Puga4,3, Brandie D Taylor5,6, David Lakey3, Divya A Patel3.   

Abstract

OBJECTIVES: Provision of long-acting reversible contraception (LARC) after delivery and prior to discharge is safe and advantageous, yet few Texas hospitals offer this service. Our study describes experiences of Texas hospitals that implemented immediate postpartum LARC (IPLARC) programs, in order to inform the development of other IPLARC programs and guide future research on system-level barriers to broader adoption.
METHODS: Eight Texas hospitals that had implemented an IPLARC program were identified, and six agreed to participate in the study. Interviews with 19 key hospital staff covered (1) factors that led the development of an IPLARC program; (2) billing, pharmacy, and administrative operations related to implementation; (3) patient demand and readiness; (4) the consent process; (5) staff training; and (6) hospital plans for monitoring and evaluation of IPLARC services.
RESULTS: Most hospitals in this study primarily served Medicaid and un- or under-insured populations. Participants from all six hospitals perceived high levels of patient demand for IPLARC and provider interest in providing this service. The major challenges were related to financing IPLARC programs. Participants from half of the hospitals reported that leadership had concerns about financial viability of providing IPLARC. The hospitals with the longest-running IPLARC programs were safety net hospitals with family planning training programs. CONCLUSIONS FOR PRACTICE: We found that hospitals with IPLARC programs all had strong support from both providers and hospital leadership and had funding sources to offset costs that were not reimbursed. Strategies to reduce the financial risks related to IPLARC provision could provide the impetus for new programs to launch and support their sustainability.

Entities:  

Keywords:  Hospitals; IPLARC; Medicaid; Texas

Mesh:

Year:  2019        PMID: 31363887      PMCID: PMC8168290          DOI: 10.1007/s10995-019-02763-y

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  14 in total

1.  Family planning as a cost-saving preventive health service.

Authors:  Kelly Cleland; Jeffrey F Peipert; Carolyn Westhoff; Scott Spear; James Trussell
Journal:  N Engl J Med       Date:  2011-04-20       Impact factor: 91.245

2.  The benefits of family planning training: a 10-year review of the Ryan Residency Training Program.

Authors:  Jody E Steinauer; Jema K Turk; Maura C Fulton; Kristin H Simonson; Uta Landy
Journal:  Contraception       Date:  2013-02-24       Impact factor: 3.375

Review 3.  Increasing LARC utilization: any woman, any place, any time.

Authors:  Mark Hathaway; Leah Torres; Jennifer Vollett-Krech; Hannah Wohltjen
Journal:  Clin Obstet Gynecol       Date:  2014-12       Impact factor: 2.190

4.  Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up.

Authors:  Kafiye Eroğlu; Gülcihan Akkuzu; Gülşen Vural; Berna Dilbaz; Ayşe Akin; Lale Taşkin; Ali Haberal
Journal:  Contraception       Date:  2006-09-15       Impact factor: 3.375

5.  Medicaid Administrator Experiences with the Implementation of Immediate Postpartum Long-Acting Reversible Contraception.

Authors:  Michelle H Moniz; Tammy Chang; Matthew M Davis; Jane Forman; Jessica Landgraf; Vanessa K Dalton
Journal:  Womens Health Issues       Date:  2016-02-28

6.  Working with State Health Departments on Emerging Issues in Maternal and Child Health: Immediate Postpartum Long-Acting Reversible Contraceptives.

Authors:  Charlan D Kroelinger; Lisa F Waddell; David A Goodman; Ellen Pliska; Claire Rudolph; Einas Ahmed; Donna Addison
Journal:  J Womens Health (Larchmt)       Date:  2015-09       Impact factor: 2.681

7.  Changes in uptake and cost of long-acting reversible contraceptive devices following the introduction of a new low-cost levonorgestrel IUD in Utah's Title X clinics: a retrospective review.

Authors:  Lauryn P Roth; Jessica N Sanders; Rebecca G Simmons; Holly Bullock; Elizabeth Jacobson; David K Turok
Journal:  Contraception       Date:  2018-03-21       Impact factor: 3.375

8.  Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception.

Authors: 
Journal:  Obstet Gynecol       Date:  2016-08       Impact factor: 7.661

9.  Cost-savings from the provision of specific contraceptive methods in 2009.

Authors:  Diana Greene Foster; Maria Antonia Biggs; Jan Malvin; Mary Bradsberry; Philip Darney; Claire D Brindis
Journal:  Womens Health Issues       Date:  2013 Jul-Aug

10.  Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program.

Authors:  Jennifer J Frost; Adam Sonfield; Mia R Zolna; Lawrence B Finer
Journal:  Milbank Q       Date:  2014-10-15       Impact factor: 4.911

View more
  4 in total

1.  Obtaining buy-in for immediate postpartum long-acting reversible contraception programs in Texas hospitals: A qualitative study.

Authors:  Kristine Hopkins; Courtney Remington; Michelle A Eilers; Saul D Rivas; Cristina Wallace Huff; Lee David Moore; Raymond Moss Hampton; Tony Ogburn
Journal:  Contraception       Date:  2021-11-05       Impact factor: 3.051

2.  Patients' Experiences with an Immediate Postpartum Long-Acting Reversible Contraception Program.

Authors:  Cristina Wallace Huff; Joseph E Potter; Kristine Hopkins
Journal:  Womens Health Issues       Date:  2020-12-13

3.  Medicaid Payments For Immediate Postpartum Long-Acting Reversible Contraception: Evidence From South Carolina.

Authors:  Maria W Steenland; Lydia E Pace; Anna D Sinaiko; Jessica L Cohen
Journal:  Health Aff (Millwood)       Date:  2021-02       Impact factor: 9.048

Review 4.  Immediate Postpartum Long-Acting Reversible Contraception: Review of Insertion and Device Reimbursement Policies.

Authors:  Charlan D Kroelinger; Ekwutosi M Okoroh; Keriann Uesugi; Lisa Romero; Olivia R Sappenfield; Julia F Howland; Shanna Cox
Journal:  Womens Health Issues       Date:  2021-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.